Annual General Meeting of Shareholders, June 24, 2025
Exhibit 99.1
| CureVac N.V., Tübingen, Germany Annual General Meeting of Shareholders, June 24, 2025 |
|
Voting results – Overview
| Agenda Item 3 | Adoption of the annual accounts over the financial year 2024 - accepted | ||
| 140.238.267 | Number of shares for which valid votes were cast (= 62.28 % of the registered share capital) | ||
| 140.132.699 | Yes votes | 99.97 % of the valid votes cast | |
| 29.971 | No votes | 0.02 % of the valid votes cast | |
| Agenda Item 5 | Release of managing directors from liability for the exercise of their duties during the financial year 2024 - accepted | ||
| 140.238.267 | Number of shares for which valid votes were cast (= 62.28 % of the registered share capital) | ||
| 140.077.414 | Yes votes | 99.93 % of the valid votes cast | |
| 84.986 | No votes | 0.06 % of the valid votes cast | |
| Agenda Item 6 | Release of supervisory directors from liability for the exercise of their duties during the financial year 2024 - accepted | ||
| 140.238.267 | Number of shares for which valid votes were cast (= 62.28 % of the registered share capital) | ||
| 139.980.864 | Yes votes | 99.87 % of the valid votes cast | |
| 181.750 | No votes | 0.13 % of the valid votes cast | |
| Agenda Item 7 | Appointment of Axel Sven Malkomes as member of the Company´s management board - accepted | ||
| 140.238.267 | Number of shares for which valid votes were cast (= 62.28 % of the registered share capital) | ||
| 140.139.165 | Yes votes | 99.93 % of the valid votes cast | |
| 90.536 | No votes | 0.06 % of the valid votes cast | |
| Agenda Item 8 | Reappointment of Jean Stéphenne as member of the Company's supervisory board - accepted | ||
| 140.238.267 | Number of shares for which valid votes were cast (= 62.28 % of the registered share capital) | ||
| 139.838.439 | Yes votes | 99.71 % of the valid votes cast | |
| 394.767 | No votes | 0.28 % of the valid votes cast | |
1
| CureVac N.V., Tübingen, Germany General Meeting of Shareholders, June 24, 2025 |
|
| Agenda Item 9 | Appointment of Mehdi Shahidi as member of the Company's supervisory board - accepted | ||
| 140.238.267 | Number of shares for which valid votes were cast (= 62.28% of the registered share capital) | ||
| 140.157.629 | Yes votes | 99.94 % of the valid votes cast | |
| 71.465 | No votes | 0.05 % of the valid votes cast | |
| Agenda Item 10 | Reappointment of Debra Barker as member of the Company's supervisory board - accepted | ||
| 140.238.267 | Number of shares for which valid votes were cast (= 62.28 % of the registered share capital) | ||
| 140.113.153 | Yes votes | 99.91 % of the valid votes cast | |
| 116.825 | No votes | 0.08 % of the valid votes cast | |
| Agenda Item 11 | Reappointment of Craig A. Tooman as member of the Company's supervisory board - accepted | ||
| 140.238.267 | Number of shares for which valid votes were cast (= 62.28 % of the registered share capital) | ||
| 137.277.554 | Yes votes | 97.89 % of the valid votes cast | |
| 2.955.849 | No votes | 2.10 % of the valid votes cast | |
| Agenda Item 12 | Reappointment of Klaus Schollmeier as member of the Company's supervisory board - accepted | ||
| 140.238.267 | Number of shares for which valid votes were cast (= 62.28 % of the registered share capital) | ||
| 139.399.557 | Yes votes | 99.40 % of the valid votes cast | |
| 833.933 | No votes | 0.59 % of the valid votes cast | |
| Agenda Item 13 | Reappointment of the external auditor for the financial year 2026 - accepted | ||
| 140.238.267 | Number of shares for which valid votes were cast (= 62.28 % of the registered share capital) | ||
| 140.174.534 | Yes votes | 99.96 % of the valid votes cast | |
| 52.382 | No votes | 0.03 % of the valid votes cast | |
2
| CureVac N.V., Tübingen, Germany General Meeting of Shareholders, June 24, 2025 |
|
| Agenda Item 14 | Authorisation of the management board to issue shares and to grant rights to subscribe for shares in the Company's capital - accepted | ||
| 140.238.267 | Number of shares for which valid votes were cast (= 62.28 % of the registered share capital) | ||
| 135.547.540 | Yes votes | 96.66 % of the valid votes cast | |
| 4.682.008 | No votes | 3.33 % of the valid votes cast | |
| Agenda Item 15 | Authorisation of the management board to limit or exclude pre-emption rights - accepted | ||
| 140.238.267 | Number of shares for which valid votes were cast (= 62.28 % of the registered share capital) | ||
| 135.566.093 | Yes votes | 96.67 % of the valid votes cast | |
| 4.656.298 | No votes | 3.32 % of the valid votes cast | |
| Agenda Item 16 | Amendment to the compensation of the members of the Company's supervisory board - accepted | ||
| 140.238.267 | Number of shares for which valid votes were cast (= 62.28 % of the registered share capital) | ||
| 136.562.291 | Yes votes | 97.39 % of the valid votes cast | |
| 3.659.762 | No votes | 2.61 % of the valid votes cast | |
3